PHARVARIS N V's ticker is PHVS and the CUSIP is N69605108. A total of 34 filers reported holding PHARVARIS N V in Q1 2021. The put-call ratio across all filers is - and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $32,630,516 | +62.5% | 1,563,513 | +17.9% | 3.44% | +7.0% |
| Q2 2023 | $20,078,668 | +104.8% | 1,326,200 | +139.9% | 3.21% | +155.0% |
| Q3 2021 | $9,803,000 | -41.7% | 552,882 | -38.8% | 1.26% | -38.3% |
| Q2 2021 | $16,821,000 | -33.6% | 902,882 | 0.0% | 2.04% | -25.8% |
| Q1 2021 | $25,335,000 | – | 902,882 | – | 2.75% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management IV, LLC | 3,246,926 | $26,153,989 | 13.57% |
| venBio Partners LLC | 2,278,575 | $18,353,922 | 10.17% |
| Bain Capital Life Sciences Investors, LLC | 3,180,601 | $25,620 | 3.20% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 559,387 | $4,505,862 | 1.86% |
| 5AM Venture Management, LLC | 587,600 | $4,733,118 | 1.21% |
| Sio Capital Management, LLC | 228,385 | $1,839,641 | 0.91% |
| Novo Holdings A/S | 1,329,325 | $10,714,360 | 0.71% |
| Cormorant Asset Management, LP | 816,460 | $6,577 | 0.43% |
| Soleus Capital Management, L.P. | 336,900 | $2,713,730 | 0.28% |
| GENERAL ATLANTIC, L.P. | 2,420,155 | $19,494,349 | 0.23% |